Screener
TG Therapeutics TGTX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts receivable, net | 401,565 | 305,628 |
| Inventories | 147,973 | 125,586 |
| Other current assets | 43,901 | 57,580 |
| Total current assets | 1,145,687 | 630,764 |
| Restricted cash | 1,364 | 1,342 |
| Long-term investment securities | 64,368 | 59,136 |
| Right of use assets | 7,085 | 6,278 |
| Deferred tax assets | 343,428 | 348,000 |
Document
FAQ
- What is TG Therapeutics's total current assets?
- TG Therapeutics (TGTX) reported total current assets of $1.15B in Q2 2026.
- How has TG Therapeutics's total current assets changed year-over-year?
- TG Therapeutics's total current assets increased by 72.6% year-over-year, from $663.96M to $1.15B.
- What is the long-term trend for TG Therapeutics's total current assets?
- Over 5 years (2020 to 2025), TG Therapeutics's total current assets has grown at a 0.6% compound annual growth rate (CAGR), from $611.74M to $630.76M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about TG Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude